E Fund Management Co., Ltd. Arcturus Therapeutics Holdings Inc. Transaction History

E Fund Management Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$31.23 - $42.99 $231,102 - $318,126	7,400 New	7,400 $249,000
Q2 2023 Aug 11, 2023	SELL	$23.94 - $32.36 $13,167 - $17,798	-550 Reduced 6.06%	8,523 $244,000
Q1 2023 May 11, 2023	BUY	$14.72 - $23.97 $133,554 - $217,479	9,073 New	9,073 $217,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $13,337 - $22,616	-1,022 Reduced 7.44%	12,713 $188,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $22,374 - $56,885	1,825 Added 15.32%	13,735 $216,000
Q1 2022 May 12, 2022	BUY	$17.64 - $39.57 $160,665 - $360,403	9,108 Added 325.05%	11,910 $321,000
Q1 2021 May 12, 2021	BUY	$38.75 - $86.92 $108,577 - $243,549	2,802 New	2,802 $115,000

178

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $478M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.